MARIA LUMBRAZO: Open Payments
NPI 1134351851 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 33 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $545 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $163 |
| Collegium Pharmaceutical, Inc. | 11 | $159 |
| Merz Pharmaceuticals, LLC | 3 | $55 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $47 |
| Averitas Pharma Inc. | 2 | $46 |
| Lundbeck LLC | 1 | $29 |
| Tonix Medicines, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| Medtronic, Inc. | 1 | $16 |
| Avanos Medical | 1 | $15 |
Products named: QULIPTA, XTAMPZA, Belbuca, Xeomin, UBRELVY, JOURNAVX, QUTENZA, VYEPTI.
Industry payments across NY — which companies pay providers there.
